Podcast Episodes

Back to Search
Pharmaceutical Executive Daily: Egetis Sells Priority Review Voucher for $190 Million
Pharmaceutical Executive Daily: Egetis Sells Priority Review Voucher for $190 Million

ANI Pharmaceuticals makes an offer to acquire Egetis Therapeutics as Egetis separately sells its priority review voucher for $190 million, Novartis e…

1 week, 6 days ago

Short Long
View Episode
Pharmaceutical Executive Daily: Nxera Licenses EP4 Agonist to AbbVie
Pharmaceutical Executive Daily: Nxera Licenses EP4 Agonist to AbbVie

How microgravity is opening new possibilities for drug R&D and manufacturing, a pharma funding roundup covers Boehringer Ingelheim’s up-to-$7 billion…

2 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Approves Voceryq
Pharmaceutical Executive Daily: FDA Approves Voceryq

FDA grants accelerated approval to INOVIO’s Voceryq to reduce surgical burden in recurrent respiratory papillomatosis, Brox.AI’s Hamish Brocklebank o…

2 weeks, 2 days ago

Short Long
View Episode
States Take Center Stage in the Drug Pricing Fight
States Take Center Stage in the Drug Pricing Fight

In this episode of the Pharmaceutical Executive podcast, Scott LaGanga, executive vice president of state advocacy at PhRMA, discusses the expanding…

2 weeks, 2 days ago

Short Long
View Episode
Pharmaceutical Executive Daily: Pathos AI Enters Collaboration with Bristol Myers Squibb
Pharmaceutical Executive Daily: Pathos AI Enters Collaboration with Bristol Myers Squibb

Bristol Myers Squibb discloses a patient death in its Phase I CAR-T multiple sclerosis trial, Pathos AI launches multi-year collaborations with Brist…

3 weeks, 2 days ago

Short Long
View Episode
The Ron Lanton Report: A Conversation with Dr. Nadine Zawadzki
The Ron Lanton Report: A Conversation with Dr. Nadine Zawadzki

Pharmaceutical and health economist Dr. Nadine Zawadzki, Senior Director, FTI Consulting joins the Ron Lanton Report to discuss how value is defined …

3 weeks, 2 days ago

Short Long
View Episode
Pharmaceutical Executive Daily: Treasury Issues Notice to Add Biotech into Proposed COINS Act
Pharmaceutical Executive Daily: Treasury Issues Notice to Add Biotech into Proposed COINS Act

Treasury proposes adding biotechnology to its Outbound Investment Security Program, a pharma funding roundup covers Gilead’s $1.275 billion acquisiti…

3 weeks, 5 days ago

Short Long
View Episode
Building Biopharma Manufacturing for Speed, Scale, and Flexibility
Building Biopharma Manufacturing for Speed, Scale, and Flexibility

Biopharma manufacturing today is being asked to move faster, accommodate increasingly complex modalities, and respond more readily to changing devel…

3 weeks, 5 days ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Grants Ultomiris Accelerated Approval in the U.S.
Pharmaceutical Executive Daily: FDA Grants Ultomiris Accelerated Approval in the U.S.

FDA grants Ultomiris accelerated approval for primary immunoglobulin A nephropathy, a pharma funding roundup covers Alcon’s $550 million acquisition …

3 weeks, 6 days ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Approves Hibsago
Pharmaceutical Executive Daily: FDA Approves Hibsago

A new ICER and West Health report finds median drug launch prices climbed to $257,000, the FDA approves GSK’s Hibsago as the first functional-cure th…

4 weeks ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us